Pre-market Alert: Geron Corp. (GERN)

Posted in General 
June 30th, 2009

Geron Corp. (Nasdaq: GERN) shares have seen a sudden spike of more than 25% and already have traded nearly 10% of the stock’s daily average volume after announcing an exclusive global licensing agreement with General Electric Co.’s (NYSE: GE) GE Healthcare.

The companies plan to develop and commercialize cellular assay products made from human embryonic stem cells for use in drug discovery, development and toxicity screening.

Financial terms are not being disclosed.  — Mike Tarsala

Comments are closed